Market Overview

Why Spectrum Pharmaceuticals Is Trading Higher Today

Share:
Why Spectrum Pharmaceuticals Is Trading Higher Today

Spectrum Pharmaceuticals (NASDAQ: SPPI) shares are trading higher on Thursday after JMP Securities initiated coverage on the stock with an Outperform rating and announced a price target of $12 per share.

Spectrum Pharmaceuticals operates in the health care sector in the United States. As an oncology products manufacturer, it develops drugs to combat various kinds of tumors. The SPI-2012 is being developed for chemotherapy-induced neutropenia in patients with breast cancer, and EOQUIN addresses immediate intravesical instillation and post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer.

Spectrum Pharmaceuticals shares were up 7.78% at $4.50 at the time of publication on Thursday. The stock has a 52-week high of $10.57 and a 52-week low of $1.74.

Latest Ratings for SPPI

DateFirmActionFromTo
Sep 2020JMP SecuritiesInitiates Coverage OnOutperform
Aug 2020HC Wainwright & Co.MaintainsBuy
Jul 2020Cantor FitzgeraldMaintainsNeutral

View More Analyst Ratings for SPPI
View the Latest Analyst Ratings

 

Related Articles (SPPI)

View Comments and Join the Discussion!

Posted-In: why it's movingPenny Stocks Initiation Analyst Ratings

Latest Ratings

StockFirmActionPT
CMGDeutsche BankMaintains1,235.0
GMBarclaysMaintains40.0
FBarclaysMaintains9.0
AAPLPiper SandlerMaintains135.0
ALGNPiper SandlerMaintains500.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com